Cash Flow from Operating Activities: A company's cash flows from operations.
Vaxcyte, Inc. (PCVX) had Cash Flow from Operating Activities of $-655.58M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-246.51M |
|
-- |
|
-- |
|
$274.28M |
|
$-274.28M |
|
$27.78M |
|
$-246.51M |
|
$-246.51M |
|
$-246.51M |
|
$-246.51M |
|
$-246.51M |
|
$-246.51M |
|
$-274.28M |
|
$-267.25M |
|
136.09M |
|
136.09M |
|
$-1.81 |
|
$-1.81 |
|
| Balance Sheet Financials | |
$1.63B |
|
$257.37M |
|
$1.38B |
|
$3.00B |
|
$205.75M |
|
-- |
|
$111.46M |
|
$317.21M |
|
$2.69B |
|
$2.69B |
|
$2.69B |
|
131.06M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-655.58M |
$437.35M |
|
$2.01M |
|
$389.19M |
|
$175.43M |
|
$-213.77M |
|
$138.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-669.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.18% |
|
-9.18% |
|
-8.21% |
|
-9.18% |
|
$20.49 |
|
$-4.92 |
|
$-4.82 |
|